The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.00
Bid: 18.00
Ask: 20.00
Change: 0.00 (0.00%)
Spread: 2.00 (11.111%)
Open: 19.00
High: 19.00
Low: 19.00
Prev. Close: 19.00
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

US Patent Grant for Liquid G+

4 Jul 2019 07:00

RNS Number : 4308E
Directa Plus PLC
04 July 2019
 

4 July 2019

 

Directa Plus plc

("Directa Plus" or the "Company")

 

US IP Portfolio Strengthened with Patent Grant for Liquid G+

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, is pleased to announce the grant of a patent by the United States Patent and Trademark Office, relating to the Company's technology to produce a water-based dispersion of pristine graphene nanoplatelets (GNPs). The technology allows Directa Plus to create an ink based on its G+ graphene product. The grant follows the award of a US patent, announced on 27 June 2019, for the Company's core, chemical-free graphene manufacturing process which produces GNPs with a high level of purity (high carbon content, extremely low oxygen content).

 

The G+ water-based ink is a highly concentrated dispersion of pristine GNPs, which can be increased to a concentration of up to 50 per cent with the addition of a surfactant. The product's main benefit is its high degree of dispersibility in any water-based hosting formulation making the incorporation process easier. The G+ ink can be used in textiles applications to provide flame retardant properties or electrical conductivity, as well as for coating applications in, for example, the production of battery electrodes.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "This grant, following on from the recent grant of patent protection for our core manufacturing process in the US, is another milestone towards launching into US markets and a further demonstration of the strength of our IP portfolio."

 

For further information please visit http://www.directa-plus.com/ or contact:

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO

 

Marco Ferrari, CFO

 

Cantor Fitzgerald Europe (Nominated Adviser and Joint Broker)

+44 20 7894 7000

Rick Thompson, Philip Davies Will Goode (Corporate Finance)

 

Caspar Shand Kydd (Sales)

 

N+1 Singer (Joint Broker)

+44 20 7496 3069

Mark Taylor, Lauren Kettle

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson, Barnaby Hayward, Edward Lee

 

 

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.

 

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAKXLFBKDFEBBB
Date   Source Headline
18th Aug 20167:00 amRNSChange of Registered Address
14th Jul 20164:04 pmRNSHolding(s) in Company
7th Jun 20164:35 pmRNSPrice Monitoring Extension
2nd Jun 20164:40 pmRNSSecond Price Monitoring Extn
2nd Jun 20164:35 pmRNSPrice Monitoring Extension
27th May 20164:09 pmRNSHolding(s) in Company
27th May 20168:01 amRNSAdmission and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.